NanoViricides
NNVC
#10384
Rank
NZ$54.58 M
Marketcap
NZ$2.37
Share price
3.08%
Change (1 day)
2.87%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): NZ-$1.03

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$1.08. an increase over its 2024 EPS that were of NZ-$1.24.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025NZ-$1.12-10%
2024NZ-$1.24-5.41%
2023NZ-$1.315.71%
2022NZ-$1.24-13.58%
2021NZ-$1.44-66.11%
2020NZ-$4.241.7%
2019NZ-$4.16-10.98%
2018NZ-$4.68-22.35%
2017NZ-$6.03-10.53%
2016NZ-$6.73375%
2015NZ-$1.42-85.19%
2014NZ-$9.5742.11%
2013NZ-$6.7326.67%
2012NZ-$5.32-6.25%
2011NZ-$5.6714.28%
2010NZ-$4.96100%
2009NZ-$2.48-0%
2008NZ-$2.48-33.33%
2007NZ-$3.72-0%
2006NZ-$3.724445.07%
2005NZ-$0.08189

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ$12.14-1,222.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.30-683.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.31-683.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.89-737.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ$4.86-549.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$2.22-304.92%๐Ÿ‡บ๐Ÿ‡ธ USA